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Abstract
Background: Fungal components have been shown very effective in generating Th17 responses. We investigated whether
exposure to a minute amount of C. albicans in the arthritic joint altered the local cytokine environment, leading to enhanced
Th17 expansion and resulting in a more destructive arthritis.
Methodology: Chronic SCW arthritis was induced by repeated injection with Streptococcus pyogenes (SCW) cell wall
fragments into the knee joint of C57Bl/6 mice, alone or in combination with the yeast of C. albicans or Zymosan A. During
the chronic phase of the arthritis, the cytokine levels, mRNA expression and histopathological analysis of the joints were
performed. To investigate the phenotype of the IL-17 producing T-cells, synovial cells were isolated and analyzed by
flowcytometry.
Principal Findings: Intra-articular injection of either Zymosan A or C. albicans on top of the SCW injection both resulted in
enhanced joint swelling and inflammation compared to the normal SCW group. However, only the addition of C. albicans
during SCW arthritis resulted in severe chondrocyte death and enhanced destruction of cartilage and bone. Additionally,
exposure to C. albicans led to increased IL-17 in the arthritic joint, which was accompanied by an increased synovial mRNA
expression of T-bet and RORcT. Moreover, the C. albicans-injected mice had significantly more Th17 cells in the synovium, of
which a large population also produced IFN-c.
Conclusion: This study clearly shows that minute amounts of fungal components, like C. albicans, are very potent in
interfering with the local cytokine environment in an arthritic joint, thereby polarizing arthritis towards a more destructive
phenotype.
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Introduction
Rheumatoid arthritis (RA) is a systemic joint disease with an
unknown etiology, characterized by a chronic inflammatory
infiltration of the synovial membrane, and associated with
destruction of cartilage and bone. Both genetic and environmental
factors contribute to the development of disease. Various infectious
agents, such as bacteria and viruses have long been associated with
the pathogenesis of RA [1,2]. The involvement of these micro-
organisms has not only been proposed in the initiation of arthritis,
but also in the progression and exacerbations of the disease.
Microorganisms are recognized by pattern recognition receptors
(PRR), such as Toll-like receptors (TLRs) and C-type lectins,
which are essential components of the innate immune system and
form the bridge with adaptive immunity. If the inflammatory
response is not adequate and/or the infection is not cleared
properly, persistence can eventually result in chronic or even auto-
immune inflammation [2]. Particularly TLR signaling has been
shown to play an intrinsic role in the inflammatory processes of
arthritis [3–5]. The concept that commensal pathogens affect the
pathogenesis of RA is strengthened by data from spontaneous
murine arthritis models and the notion that spontaneous arthritis
does not develop in animals kept under germ free conditions [3,6].
This implies the importance of (memory) responses for the ‘break
of tolerance’ and induction of auto-inflammation/immunity.
Candida albicans is the most common opportunistic fungal
pathogen in humans. Infection with C. albicans induces IL-17
producing T helper (Th17) cells in vitro and in vivo in naı¨ve mice [7–
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9]. Under physiological conditions, these Th17 cells produce
proinflammatory cytokines like IL-17A (IL-17), IL-17F, IL-21 and
IL-22, and are involved in the clearance of several extracellular
bacteria and fungi [10]. In the arthritic joint, direct or indirect
effects of IL-17/Th17 result in increased inflammation, angio-
genesis, and osteoclastogenesis, resulting in enhanced breakdown
of cartilage and bone [11–14]. Although C. albicans or Candida-
derived b-glucan have been shown to induce and aggravate
various models of arthritis [15,16], these observations have not yet
been linked to modulation of the IL-17/Th17 pathway and
increased structural damage.
The purpose of the present study was to demonstrate the ability
of C. albicans to skew the T-cell balance in the chronic murine
SCW model. This model initiates as a local TNF-dependent
macrophage-driven inflammation, at which repeated antigen
exposure results in a chronic T-cell dependent arthritic process
[17]. A small quantity of C. albicans or Zymosan A (,10% of mass)
was added to the cell wall fragments of Streptococcus pyogenes (SCW)
that were repeatedly injected into the knee joint. During the
chronic phase of the arthritis, the development of macroscopic
joint swelling and histopathological changes in synovium, carti-
lage, and bone were determined. Furthermore, the levels of
antibodies, secretion of T-cell cytokines and presence of T-cells
were examined.
Materials and Methods
Animals
Male C57Bl/6 mice were purchased from Janvier, France. The
mice were housed in filter-top cages; water and food were
provided ad libitum. The mice used were between 10–12 weeks of
age. All animal procedures were approved by the animal ethics
committee of the Radboud University Nijmegen.
Study protocol
Steptococcus pyogenes T12 organisms were cultured and prepared
as described previously [17]. For the fungal components, the
blastoconidia of Candida albicans (ATCC MYA-3573 (UC 820))
were used [8]. Zymosan A (Saccharomyces Cerevisiae) was purchased
from Sigma-Aldrich and prepared as described earlier [18].
Chronic unilateral arthritis was induced by repeated intra-
articular (i.a.) injection of 25 mg SCW on days 0, 7, 14, and 21,
whether or not with 1*105 particles of C. albicans (1*105<1 mg) or
2 mg Zymosan, in 7 ml phosphate buffered saline (PBS) into the
right knee joint of naive mice. As a control, additional groups were
injected with the fungal particles alone. On day 22, twenty-four
hours after the last injection, a subgroup of mice was sacrificed for
the collection of synovial washouts. Accordingly, patellae with
surrounding soft tissue were isolated from inflamed knee joints and
cultured 1 hour at RT in RPMI-1640 medium containing 0.1%
BSA (200 ml/patella). In addition, the draining lymph nodes
(popliteal and inguinal) were collected and cells were isolated.
Then, 1*105 cells were stimulated for 72 hours with 2 mg/ml plate
bound anti-CD3 (R&D systems) and 2 mg/ml plate bound anti-
CD28 (BD Biosciences). Thereafter, supernatants were collected,
centrifuged and stored for cytokine determination. On day 28,
during the chronic joint inflammation, the sera from the
remaining mice were collected, the mice were sacrificed, and
knee joints were prepared for histology.
Measurement of joint swelling
Joint swelling was assessed by measuring the accumulation of
99 mTc in the inflamed joint due to increased blood flow and
edema. Therefore, 0.74 MBq of 99 mTc in 200 ml of saline was
injected subcutaneously. After several minutes of distribution
throughout the body, external gamma radiation in the knee joints
was measured. Swelling was expressed as the ratio of gamma
counts in the right (inflamed) knee joint to gamma counts in the
left (control) knee joint. Values higher than 1.1 counts per minute
were considered to represent joint swelling.
Histopathology
For standard histological assessment, the isolated joints were
fixed for 4 days in 10% formalin, decalcified in 5% formic acid,
and the specimens were processed for paraffin embedding. Tissue
sections were stained with hematoxylin and eosin. The severity of
inflammation in the joints was scored on a scale of 0–3 (0 = no
cells, 1 = mild cellularity, 2 = moderate cellularity, and 3 = maxi-
mal cellularity). Bone destruction was graded on a scale of 0–3,
ranging from no damage to the complete loss of bone structure.
Proteoglycan (PG) depletion was determined using Safranin O
staining. Loss of proteoglycans was scored on a scale of 0–3,
ranging from normal, fully stained cartilage to destained cartilage,
fully depleted of PG. The scoring of the sections was performed in
a blinded manner.
Cytokine detection
Cytokine levels were measured using Luminex multi-analyte
technology in combination with Bio-Plex cytokine kits (Bio-Rad;
IL-17, IL-4, IFN-c, IL-10) and performed according to manufac-
turer’s instructions.
Quantitative PCR
RNA was isolated from synovial knee biopsies using TRI-
reagent (Sigma) and treated with DNase to remove genomic DNA.
The RNA was subsequently reverse transcribed with oligo(dT)
primers in a reverse transcriptase procedure. Quantitative real-
time PCR was performed with cDNA specific primers (Biolegio)
and SYBR Green PCR Master Mix (Applied Biosystems). The
DCt method was used to normalize transcripts to GAPDH and to
calculate relative mRNA expression (22DCt), for which the
expression in the SCW injected group was arbitrarily set to 1.
All primer pairs were developed using Primer Express 2.0 (Applied
Biosystems) and validated according to protocol.
Isolation and stimulation of synovial cells
After sacrificing the mice, the ankle joint synovium was
dissected for single cell isolation. In short, synovial biopsies were
incubated with enzymatic digestion buffers (Liberase Blendzyme,
Roche) for 30 minutes at 37uC. Next, a 70 mm nylon cell strainer
(BD Falcon) was used to process the digested tissue. The cell
preparation was collected in RPMI with 10% FCS. To isolate the
single mononuclear cells, Lympholyte-M (Cederlane) was used
according to manufacturer’s protocol. All cells were cultured in
RPMI-1640 (Gibco; Invitrogen) supplemented with 10% FCS.
Subsequently, the cells were prepared for intracellular flowcyto-
metry.
Flow cytometry
Synovial cells were stimulated for 5 hours with PMA (50 ng/ml;
Sigma) and ionomycine (1 mg/ml; Sigma) in the presence of
Golgiplug (BD Biosciences) according to manufacturers protocol.
After staining the cells extracellularly with anti-CD3 APC (BD
Biosciences), the cells were fixed and permeabilized with Cytofix/
Cytoperm solution (BD Biosciences). Subsequently, they were
intracellularly stained with anti-IFN-c PE (BD Biosciences) and
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anti-IL-17 FITC (BD Biosciences). Samples were measured on a
FACS Calibur and data were analyzed using FlowJo software.
Determination of anti-SCW antibody levels
Levels of anti-SCW antibodies in the serum of mice with
chronic SCW-induced arthritis (day 28) were analyzed according
to standard methods [17]. Briefly, 10 ng of SCW fragments were
coated overnight onto 96-well plates. Thereafter, plates were
washed, and nonspecific binding was blocked with 1% BSA in
PBS-Tween 80 (0.05%). Anti-SCW antibodies were examined in
serial 26 dilutions, starting with an initial dilution of 206. After
incubation for 1 hour, plates were washed and isotype-specific
goat anti-mouse Ig–HRP (1:1,000) was added for 1 hour at room
temperature.
Statistical analysis
Results are expressed as the mean 6 SEM. Differences between
experimental groups were tested using Mann-Whitney U-test or
Figure 1. Candida albicans and Zymosan A aggravate the inflammation in the chronic SCWmodel. On days 0, 7, 14, and 21, streptococcal
cell wall (SCW) fragments were injected intra-articularly (i.a.) into the knee joint. Joint swelling (ratio of 99 mTc uptake in the treated right knee joint to
that in the untreated left knee joint) were determined 1 day after every injection (A) and during the chronic phase of the model on day 28 (B; n = 6
mice/group). In addition, the inflammatory cell influx (C) on histological slides was quantified on day 28. H&E stained frontal knee sections (original
magnification 1006) (D) are shown (n = 8 mice/group. Values are the mean 6 SEM; ns = non significant, * P,0.05, ** P,0.01, *** P,0.001, by One-
way ANOVA.
doi:10.1371/journal.pone.0038889.g001
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one-way analysis of variance with Dunnett’s multiple comparison
test, as appropriate. P-values less than 0.05 were considered
significant.
Results
Exposure to fungal particles aggravates chronic SCW
arthritis
Repeated intra-articular injection of SCW bacterial fragments
induce arthritic flares that shift from a predominantly macro-
phage-driven acute inflammation to a T-cell driven chronic
inflammation [17]. To investigate the ability of C. albicans to
effectively alter the local synovial inflammatory process, heat-killed
conidia of C.albicans were co-injected with 25 mg SCW fragments
in the knee joint on day 0, 7, 14 and 21. In preliminary
experiments, exposure to differential doses of C. albicans to
murine peritoneal macrophages resulted in the production of
various innate cytokines like TNF-a, IL-1b and IL-6 (figure S1).
Subsequently, during a pilot experiment, we selected a dose of
1*104 conidia of C. albicans, which we co-injected with the SCW
fragments into the knee joint. This dose did not show a significant
alteration in arthritis severity/score (data not shown). We therefore
increased the dose of C. Albicans to 1*105 on top of the SCW dose
of 25 mg. For comparison, we injected 2 mg Zymosan A, a glucan
derived from the yeast cell wall of Saccharomyces Cerevisiae, known for
its adjuvant properties [19–21]. As control, mice were injected i.a.
with SCW, C. albicans or Zymosan A alone.
The control mice injected with C. albicans or Zymosan A alone
did not develop joint swelling after the injections (figure 1A).
Furthermore, the co-injection of C. Albicans or Zymosan A on top
of the SCW fragments did not result in an increased joint swelling
compared to the SCW injected group during the acute phase of
the model. On the contrary, one day after the final injection, on
day 22, the C. Albicans co-injected group showed a significant
increase in the technetium measurements, whereas the Zymosan A
co-injected group only showed a trend for increase. Accordingly,
we analyzed the joint swelling and histology during the chronic
phase of the model, on day 28. During this phase, the joint
swelling in the mice injected with SCW remained significantly
increased (figure 1B). Interestingly, exposure to minute amounts of
C. albicans or Zymosan A on top of the SCW fragments
significantly aggravated the joint swelling. This increase in joint
swelling in both the C. albicans and Zymosan A injected mice was
supported by a significant increase in the influx of inflammatory
cells after histopathological analysis (figure 1 panels C and D),
indicating that both fungal particles aggravated the inflammatory
process during the chronic phase of the model.
Increased joint destruction in SCW arthritis after co-
exposure to C. albicans
To compare the ability of C. albicans and Zymosan A to affect
the cartilage and bone destruction, we performed a detailed
histological analysis. Compared to the SCW-injected mice, the
increased joint inflammation at day 28 after co-injection of SCW
with fungal particles was accompanied by marked proteoglycan
depletion (figure 2A). Remarkably, although the influx of
inflammatory cells was comparable after addition of either C.
albicans or Zymosan A, we observed a significantly higher increase
in cartilage erosion, chondrocyte death and bone erosion in the C.
albicans co-injected group compared to the SCW injected group
(figure 2A), suggesting that Candida exposure modulates towards a
more destructive immune response.
In addition, we analyzed the mRNA expression of several
inflammatory genes involved in bone and cartilage destruction
Figure 2. Exposure to C. albicans increases the cartilage
destruction and bone erosion during chronic SCW arthritis.
Analysis of destructive parameters after 4 relapsing flares of arthritis. On
day 28, knee joints (n = 8/group) were harvested for histological
assessment. Knee joint sections were stained using Safranin O to
determine the degree of proteoglycan (PG) depletion. H&E staining was
used to score the degree of chondrocyte death, cartilage surface erosion
and bone erosion (A). QPCR analysis of destructive related genes was
performed on synovial biopsies (n= 3/group) of day 22, one day after the
last injection (B). Representative images of arthritic knee joints showing
immunohistochemical staining for VDIPEN after the 4 repeated injections
(day 28) (C). Besides, the quantitative measurement of VDIPEN expression
(percentage of positively stained area) in the cartilage of the 3 groups of
mice (n= 8/group) was analyzed. Values are the mean 6 SEM; ns = non
significant * P,0.05, ** P,0.01, *** P,0.001, by One-way ANOVA.
doi:10.1371/journal.pone.0038889.g002
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using synovial tissue collected during the chronic phase of the
arthritis. While the osteoclast marker Cathepsin K (Cat.K) was not
significantly enhanced, RANKL was upregulated in the synovium
in both the C. albicans and Zymosan A induced groups, in line with
to the increase in bone erosion. Moreover, the matrix metallo-
proteinase’s MMP3 and MMP13 were significantly increased in
the synovium of C. albicans inoculated mice compared to the single
SCW group, corresponding to the increased cartilage erosion
(figure 2B).
To support that the increase in cartilage destruction was
induced by a matrix metalloproteinase–mediated process, we
examined the expression of the MMP-specific aggrecan neo-
epitope VDIPEN by immunohistochemistry. Repeated SCW
injections were sufficient to induce VDIPEN expression at the
cartilage sites (figure 2C). The expression of VDIPEN after four
weeks of SCW arthritis was comparable to the Zymosan A co-
injected mice. However, in line with the increase in MMP mRNA
expression, the amount of VDIPEN expression increased dramat-
ically when C. albicans had been co-injected with SCW into the
joints. These findings show that a small amount of C. albicans is
sufficient to exacerbate the chronic murine SCW arthritis model
by increasing the cartilage and bone destruction.
Exposure to C. albicans during chronic SCW arthritis
skews the T cell cytokine profile towards Th17 responses
To study modification of the adaptive immune responses, we
initially studied the B-cell compartment and determined the levels
of anti-SCW antibodies of total IgG, IgG1 and IgG3 in the sera of
the mice. We previously demonstrated that in the chronic SCW
model, antigen-specific antibodies are induced after the fourth i.a.
injection of SCW fragments [22]. As can be appreciated from
figure 3A, we observed no differences in the serum levels of SCW
specific antibodies between the groups, indicating that the B-cell
antibody production was not altered after addition of C. albicans or
Zymosan A.
Since T helper cells are crucial for the chronic phase of the
SCW arthritis model, and Candida is known for the induction of
Th17 cells, we explored alterations in T-cell responses. Pan T-cell
stimulation with anti-CD3 and anti-CD28 of draining lymph node
cells on day 22 revealed no difference in the levels of IL-4 and IL-
10 production. Interestingly, a significant increase in IL-17
production and a tendency for increased IFN-c production were
found, suggesting an enhanced helper T cell response of mainly
the Th17 lineage by the addition of C. albicans (figure 3B).
To conclude whether this peripheral increase in IL-17 and IFN-
c represented a shift in the local T-cell balance in the arthritic
joint, we measured the same T-cell derived cytokines in the
synovial washouts of the mice. IFN-c and IL-10 levels were not
altered, and IL-4 was undetectable (figure 3C). In contrast, the IL-
17 levels were significantly increased in the C. albicans co-injected
group, while the cytokine levels in the Zymosan A co-injected
group were not different from the SCW group. All together, these
data suggest that C. albicans induces a shift in the T cell
compartment during SCW arthritis, favoring Th17.
C. albicans mainly induces IL-17-producing T cells in the
joint
To establish a shift in the T-cell compartment, we subsequently
determined the levels of T-cell transcriptional lineage factors,
which specify the different T helper cell lineages. FOXP3 (Treg)
and GATA3 (Th2) mRNA expression levels were not significantly
different between the SCW-arthritis groups (figure 4A). In line
with the enhanced IL-17 production from the lymph nodes, we
observed a significant increase in the mRNA expression of the
Th17 transcription factor RORcT after C. albicans injection.
Remarkably, although the level of IFN-c was not significantly
increased in the synovial washouts, we did observe an increase in
Th1 transcriptional lineage factor T-bet. Co-exposure to Zymosan
A did not influence the other transcription factors. To further
confirm the Th17 profile, we analyzed the expression of IL-17A,
IL-17F, IL-21, IL-22 and IFNy (figure 4B). Here we again
observed a significant increase in the expression of IL-17A, IL-21
and IFNy. Although a trend for an increase was found for the
other Th17 profile cytokines, they were not significantly increased
in the C. albicans co-injected group compared to the SCW and
SCW+Zymosan A groups.
Next, we determined whether the inoculation of C. albicans in
the chronic SCW model affected the phenotype of the infiltrated
T-cells. On day 22, at the peak of the inflammation, we dissected
the inflamed synovium and isolated the residing cells. Intracellular
cytokine staining revealed an increased percentage of single IL-17
producing T-cells (figure 4B, C). Further analysis revealed that a
subpopulation of these IL-17 producing T cells, also produced
IFN-c, partly explaining the increase in the Th1 transcription
factor T-bet. This indicates that in the presence of C. albicans the
T-cell balance during SCW-arthritis is shifted towards a
pronounced Th17/Th1 profile.
Discussion
Our main finding is that a low-grade exposure to C. albicans can
skew the T cell balance in the SCW arthritis model, by inducing
Th17 cells and pushing it towards a more destructive arthritis
model. This indicates that the presence of a minute amount of C.
albicans antigen, after e.g. a mucosal infection, might be sufficient to
skew an inflammatory cytokine profile.
Microbial infections have long been associated with the
pathogenesis of RA. Therefore, several fungi and fungal-derived
ligands have been used to provoke or accelerate arthritic processes.
In the last decade, several PRR’s that recognize fungal PAMPs
have been identified, in particular Toll-like receptors (TLR-2 and
TLR-4) and C-type lectin family members (Dectin-1, Dectin-2 and
mannose receptor) [6,15,16,18,20,23]. C. albicans is especially
known for the induction of Th17 cells via Dectin-1, TLR-2,
TLR4, Mannose receptor, and complement [8,24] Earlier, it has
been shown that gut colonization by C. albicans or exposure to C.
albicans derived b-glucans can initiate and aggravate collagen-
induced arthritis, probably via an increased and/or altered
cytokine profile [16,25]. Although this shows that C. albicans can
initiate and aggravate arthritis models, it was not known whether
and how Th17 responses were mechanistically involved.
To explore the potency of a minute amount of C. albicans on
skewing T-cell responses during arthritis, we investigated the
chronic SCW model. In this model, chronic T cell dependent
arthritis is induced by repetitive intra-articular injection of
Steptococcus pyogenes cell wall (SCW) fragments [17]. S. pyogenes is a
common Gram-positive bacteria that can induce severe rheumatic
fever and/or reactive arthritis, depending on the host response
[26]. Previously, we have shown that intra-articular exposure to
SCW mainly depends on macrophage activation via TLR-2/
MyD88 pathway [27]. Repeated exposure results in a chronic
arthritis involving SCW-specific T- and B-cell memory responses,
without the need for adjuvants like Freund’s complete adjuvant.
Furthermore, although the model involves a chronic phase that is
characterized by an IL-1 and IL-17 dependent cartilage destruc-
tion, the model is less destructive compared to collagen-induced
arthritis (CIA) and hardly involves bone erosions. We hypothesized
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that co-exposure to C. albicans, would alter the macrophage-
derived cytokine production during the flares, aggravating the
chronic disease.
Monocytes and macrophages stimulated with C. albicans induce
pro-inflammatory cytokine production, like TNF-a, IL-1 and IL-6
[24]. To prevent an aggravation of the SCW-induced arthritis by
the addition of Candida, we choose the dose of C. Albicans at such
a subtle level that it did not cause a significant increase in the joint
swelling on top of the S. pyogenes cell wall (SCW) induced local
inflammation. During this acute phase of the SCW arthritis model,
joint swelling is TNF-a dependent [28]. We therefore conclude
that a possible Candida-induced increase in TNF-a could not be
observed by our TNF-dependent Tc-measurement. Even three
weeks of repeated co-injections with C. albicans or Zymosan did not
significantly accelerate the model, showing that the co-exposure to
C. albicans did not increase the innate immune response like a
classical adjuvant [29], but may have prolonged or altered the
immune response.
Figure 3. C. albicans skews T-cell cytokine profile. Serum levels of anti-SCW-specific total IgG, IgG1, and IgG3 antibodies (A). Draining lymph
node cells (1*105/well) were stimulated with anti-CD3/anti-CD28 antibodies for 72 hours (n = 6/group). Levels of IFN-c, IL-17 and IL-10 were
determined by Luminex in the supernatants of the stimulated lymph node cells (B) and washouts of synovial biopsies of day 22 (C). Results are the
mean 6 SEM; ns = non significant * = P,0.05; ** = P,0.01, *** = P,0.001, by One-Way ANOVA.
doi:10.1371/journal.pone.0038889.g003
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This was further strengthened by the fact that we observed no
changes in classes of SCW-specific immunoglobulin production.
These SCW specific antibodies can be detected in sera during the
late chronic stage, and are also TNF-a dependent [17].
Interestingly, B-cells were reported to be involved in the Th17
response after C. albicans exposure [30]. And although B-cells play
a minor role in the repeated SCW arthritis model [17], co-
exposure to C. albicans might have altered the antigen presenting
function of B-cells. The presence of autoantibodies, like rheuma-
toid factor (RF) and anti-citrullinated petide antibodies (ACPA) in
the sera of patients are early predictors of disease and correlate
with arthritis severity [31].
At day 22, one day after the last injection, when the model shifts
from a predominately macrophage driven model to a T cell
dependent model, we observed a significantly increased joint
swelling in the Candida co-injected group, with a trend for
increase in the Zymosan co-injected mice. Furthermore, during
the late chronic phase of the model (at day 28) we observed a
prolonged increase in joint swelling after co-exposure to both C.
albicans or Zymosan A. Interestingly, although the increase in joint
swelling and inflammatory cell influx in the C. albicans co-injected
mice was comparable to Zymosan A co-injected mice, the
chondrocyte death, bone erosion and cartilage erosion were
significantly elevated by C. albicans. Additional analysis revealed
that during the chronic phase of the model, the C. albicans exposure
contributed to the increased MMP-mediated cartilage destruction
and increased bone erosion, suggesting that additional processes
were involved in the C. albicans exposed joints. This increase in
joint destruction was accompanied by local synovial IL-17
expression, which is thought to/may enhance the role of TNF-a
in the progression of the destructive process [32–34]. Synergy
between IL-17 and TNF-a may underlie the increased pathology
in the C. albicans co-injected group. Together, we concluded that
the low levels of C. albicans and Zymosan A did not accelerate the
model during the first three weeks of repeated antigen injections,
but addition of C. albicans did alter the T cell balance and arthritis
outcome at the end of the experiment.
Focusing on the T-cell cytokine production, we observed an
increased Th17/Th1 cytokine profile. In line with the increase in
the transcriptional factors T-bet and RORcT, this increase was
related to an increase in IL-17 single and double positive T-cells.
Furthermore, over 90% of the total IL-17 producing cells were
CD3+ (data not shown). This supports that T lymphocytes are the
main source of IL-17 in this model, rather than innate immune
cells capable of producing IL-17 [35].
T helper cells are defined T lymphocytes expressing CD4
glycoprotein on their cell surface. We chose CD3 staining over
CD4 staining due to the reported sensitivity of CD4 to cleavage
during enzymatic digestion of the studied tissue [36]. Only
recently, we have altered the protocol of enzymatic digestion
slightly, to prevent CD4 cleavage. In a yet unpublished
observation (submitted manuscript) we observed that in the
SCW model more than 80% of the IL-17+ producing cells
express CD4.
Apparently, C. albicans does not only increase the ‘classical’ IL-
17 producing T-cells, but also promotes the transition to a Th1/
Th17 mixed phenotype. The role and induction of Th1 profile
versus Th17 profiles in models have received increased attention.
In human RA, IFN-c producing T helper cells are found at the
level of the synovial tissue rather than IL-17 producing T helper
cells [37,38], whereas the experimental arthritis models do
illustrate an important role for IL-17 [14]. The strength of the
IFN-c response seems to determine the dependency on IFN-c or
IL-17 [39]. Remarkably, isolated IFN-c producing T helper cells
from patients with chronic inflamed joints show more resemblance
with ‘classical’ Th17 cell surface repertoire compared to ‘classical’
Th1 cells [40,41]. In addition, recent reports have shown the
plasticity of Th17 cells in vivo, that shift towards IFN-c producing
cells during chronic autoimmune inflammation [42,43]. Both IL-
12 and IL-23 might be important players for this transition
[41,42,44].
On the other hand, recent studies have shown an inverse
relationship between Th17 cells and regulatory T cells [45]. Tregs
in the joints of RA patients can inhibit the production of IFN-c
and IL-17 [46]. Although we did not observe a significant
alteration in the FOXP3 levels, the increased IL-6 levels after C.
albicans exposure, might contribute to the imbalance between
Th1/Th17 and Tregs cells [47]. These results raise questions
about the ancestry and transcriptional control of Th17 during the
course of chronic inflammatory diseases, such as Rheumatoid
Arthritis. Clarifying pathways that control the induction of these
double positive cells in vivo during arthritis will lead to new
strategies for the development of novel therapeutic interventions in
the Rheumatic diseases.
In conclusion, exposure to a small amount of the fungal
pathogen C. albicans is sufficient to shift the T-cell balance of the
synovial immune response towards a more pronounced Th17/
Th1 profile, thereby aggravating the model towards increased
cartilage and bone destruction. In the past others have shown that
fungal particles, like C. albicans, can accelerate or aggravate
arthritic disease. This is the first report showing that this
aggravation involves the induction of Th17 cells in vivo. C. albicans
is a common commensal that can cause mucosal and systemic
infections [48]. Whether C. albicans can contribute to the
progression of joint destruction in RA remains to be elucidated.
Supporting Information
Figure S1 Candida albicans and Zymosan A induce a
different cytokine profile in vitro. 1*105 peritoneal macro-
phages from naive C57Bl/6 mice were stimulated with different
concentrations Zymosan or C. Albicans for 16 hours (n = 5). Levels
of IL-1b, IL-6, IL-10 and TNF-a were determined by Luminex in
the supernatants. Results are mean 6 SEM.
(TIF)
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